HMB has spent three decades in the wrong aisle.
It sits on the shelf between the pre-workouts and the protein powders, marketed to lifters, sold to people chasing bigger muscles and heavier lifts. It has a compelling backstory as a “natural anabolic” and a loyal following in gym culture.
There’s just one inconvenient detail.
In the population it’s mainly sold to — trained, healthy, muscular young people — the evidence says it does close to nothing.
That’s not a knock on the molecule. It’s a case of mistaken identity.
Because when you look at where HMB does show real, if modest, effects, it’s almost the mirror image of its marketing: older, frailer, more sedentary, sometimes ill.
HMB isn’t a weak muscle-builder.
It’s a decent muscle-protector that has spent its whole commercial life pitched to the people who need protecting least.
What HMB Actually Is
HMB, or beta-hydroxy beta-methylbutyrate, is not something foreign.
It’s a metabolite your body already makes from leucine, one of the branched-chain amino acids in any protein-rich meal. When you eat leucine, a small fraction, only around 5 percent, gets converted into HMB. Supplementing HMB simply delivers a concentrated dose of that downstream product directly, bypassing the inefficient conversion.
Leucine itself is a well-known trigger for muscle protein synthesis, which is presumably why HMB inherited the “anabolic” reputation. If leucine builds muscle and HMB comes from leucine, the logic goes, HMB must build muscle too.
The typical dose landed on in research is about 3 grams a day, and its safety profile across decades of study is reassuringly clean. The trouble with the “HMB builds muscle” story isn’t the safety or the dose. It’s that the logic skips over what HMB actually does once it’s in you, which turns out to be a different job than the marketing implies.
How It Ended Up in the Gym
HMB’s misfiling wasn’t a conspiracy. It was an accident of history, and the history is worth knowing.
The compound was developed at Iowa State University in the 1990s, and its roots are in animal nutrition research rather than sports science. It arrived in the human supplement market in 1996 amid breathless coverage, and demand was immediate. Within months it was being sold as a bulk-up pill. The “natural anabolic” framing stuck so firmly that it has survived nearly thirty years of less flattering research.
Here’s the detail that matters, and it’s uncomfortable. The founding study was run by the holder of the HMB patent, and it reported the largest muscle gain ever recorded for the compound.
No subsequent study has come close. When later researchers pooled the trials together, that single outlier was doing remarkable amounts of work. Analysts noted that removing the original study would leave no difference between HMB and placebo at all.
A thirty-year reputation, in other words, rests substantially on one unusually positive result from an interested party.
Everything that followed has been a slow regression toward zero — and the regression has been steepest in exactly the population the marketing targets. A separate meta-analysis found only trivial gains in trained men, with a somewhat larger effect in untrained ones, which is the first hint of the pattern that organizes this whole story.
The Mechanism Everyone Skips Past
Here is the detail that reframes the entire supplement. HMB’s main effect isn’t building muscle. It’s slowing the breakdown of muscle.
Muscle tissue is in constant flux, simultaneously being built up through protein synthesis and torn down through protein breakdown. Your muscle mass at any moment is the net balance of those two opposing processes. A supplement could tilt that balance by pushing synthesis up, by holding breakdown down, or both.
HMB does a little of the first and a lot of the second.
It has a modest ability to stimulate the mTOR pathway that drives protein synthesis. But its more powerful and better-documented action is anti-catabolic. It suppresses the ubiquitin-proteasome system, the cellular machinery that dismantles muscle protein. In plain terms, HMB is less an engine that builds muscle and more a brake that stops muscle from being lost.
That single distinction explains almost everything strange about HMB’s track record. A brake is only useful if you’re rolling downhill. And whether you’re rolling downhill depends entirely on who you are.
Why It Does So Little for Lifters
Picture a healthy young person who trains hard, eats plenty of protein, and sleeps enough. Their muscle is in an overwhelmingly favourable state. Protein synthesis is high, driven by training and food, and protein breakdown is relatively low.
There simply isn’t much muscle loss happening for an anti-catabolic supplement to prevent.
Give that person HMB and you’re applying a brake to someone who isn’t rolling backward. The result, predictably, is very little. And that’s exactly what the research shows.
Meta-analyses in trained and competitive athletes have found no meaningful effect of HMB on strength or body composition. Effect sizes hover around zero for bench press, leg press, and fat-free mass. In young resistance-trained subjects, HMB produced no significant gains in fat-free mass or strength beyond training alone.
One well-controlled study found HMB and plain leucine produced equivalent results, undercutting the idea that HMB offers anything special.
None of this means these people wasted their effort in the gym. It means the supplement had almost nothing to do. Their muscle wasn’t breaking down fast enough for a breakdown-blocker to matter.
For the trained young athlete, HMB is answering a question their body wasn’t asking.
Where HMB Actually Earns Its Keep
Now picture the opposite person: an adult in their seventies, not especially active, perhaps recovering from an illness, a hospital stay, or a stretch of bed rest. Their muscle is in the reverse state.
Age-related anabolic resistance makes it harder to build muscle from food, and the catabolic pressures of aging, inactivity, and illness push breakdown up.
This person is, metabolically speaking, rolling downhill.
This is where a brake earns its keep. In older adults, the evidence for HMB is genuinely more favourable, though still modest and imperfect.
Meta-analyses have found that HMB supplementation helps preserve lean muscle mass in older people, and appears particularly useful for limiting the muscle atrophy caused by bed rest and immobilization.
A 2025 review of HMB combined with resistance training in older adults found modest, borderline improvements in handgrip strength. It also found more meaningful gains on a standard physical-function test, even while lean mass itself didn’t shift dramatically.
The pattern extends into clinical territory.
HMB has been studied as a tool against muscle wasting in cancer, in recovery from surgery, and in frailty. These are precisely the catabolic, high-breakdown states where an anti-catabolic agent has the most to push against.
The evidence there is still described as inconsistent and in need of stronger trials, so this isn’t a cure. But the direction is telling. HMB shows up most where muscle loss is fastest, and does least where muscle is already thriving.
Reading the Evidence Honestly
It would be easy to overcorrect here and declare HMB a miracle for older people.
The data don’t support that either, and the honest picture is more measured. Even in older adults, the effects are modest, the trials are often small, and results are inconsistent across outcomes. Some studies show benefits to function but not lean mass; others the reverse.
When HMB is added on top of resistance training in older people, several analyses find it adds little beyond what the training already delivers.
Exercise is itself a powerful anti-catabolic and anabolic stimulus. And a good deal of the supportive research involves formulations that bundle HMB with protein, vitamin D, or amino acids, making it hard to isolate HMB’s own contribution.
So the accurate statement isn’t “HMB works for the old, not the young.”
It’s narrower and more useful.
HMB’s plausible benefit is concentrated in people with elevated muscle breakdown and limited ability to build muscle, and it shrinks toward zero as a person gets younger, healthier, better fed, and more trained.
The supplement’s value tracks the catabolic state of the user, not their enthusiasm for the gym.
So Who Should Actually Consider It?
The practical guidance falls out of the mechanism cleanly.
If you’re a healthy person who trains and eats enough protein, HMB is very unlikely to do anything your training and diet aren’t already doing. Your money goes further on the basics: sufficient total protein, progressive resistance training, and sleep.
The picture changes if you’re older, dealing with frailty or forced inactivity, recovering from surgery, or facing a muscle-wasting condition. There, HMB becomes a more reasonable thing to discuss with a clinician.
It works best as one part of a plan built around adequate protein and whatever resistance exercise is feasible. Even then, it’s a supporting player, not the lead. The strongest muscle-preserving interventions in these situations remain protein and movement.
HMB is a modest adjunct that may help at the margins.
Bottom Line
HMB is a case study in how a supplement’s marketing and its evidence can point in opposite directions.
Sold for decades as a muscle-builder for lifters, it turns out to be primarily a muscle-protector, and muscle protection is close to worthless when almost no muscle is being lost. That’s why it underwhelms in the gym and shows its best, though still modest, results in the frail, the ill, and the immobilized.
The science here is more nuanced than the label, and the nuance is unusually clarifying.
HMB isn’t a bad supplement, it’s a misfiled one.
It belongs less in the pre-workout aisle and more in the conversation about aging well.
References
- Sanchez-Martinez J, Santos-Lozano A, Garcia-Hermoso A, et al. Effects of beta-hydroxy-beta-methylbutyrate supplementation on strength and body composition in trained and competitive athletes: a meta-analysis of randomized controlled trials. Journal of Science and Medicine in Sport. 2018;21(7):727-735.
- Ferreira HR, Jakubowski JS, et al. Supplementation with the leucine metabolite beta-hydroxy-beta-methylbutyrate (HMB) does not improve resistance exercise-induced changes in body composition or strength in young subjects: a systematic review and meta-analysis. Nutrients. 2020;12(5):1523.
- Rowlands DS, Thomson JS. Effects of beta-hydroxy-beta-methylbutyrate supplementation during resistance training on strength, body composition, and muscle damage in trained and untrained young men: a meta-analysis. Journal of Strength and Conditioning Research. 2009;23(3):836-846.
- Nissen S, Sharp R, Ray M, et al. Effect of leucine metabolite beta-hydroxy-beta-methylbutyrate on muscle metabolism during resistance-exercise training. Journal of Applied Physiology. 1996;81(5):2095-2104.
- Courel-Ibanez J, Vetrovsky T, Dadova K, et al. Health benefits of beta-hydroxy-beta-methylbutyrate (HMB) supplementation in addition to physical exercise in older adults: a systematic review with meta-analysis. Nutrients. 2019;11(9):2082.
- Wu H, Xia Y, Jiang J, et al. Effect of beta-hydroxy-beta-methylbutyrate supplementation on muscle loss in older adults: a systematic review and meta-analysis. Archives of Gerontology and Geriatrics. 2015;61(2):168-175.
- The role of HMB supplementation in enhancing the effects of resistance training in older adults: a systematic review and meta-analysis on muscle quality, body composition, and physical function. Nutrients. 2025 Nov 20;17(22):3624.
- Prado CM, Orsso CE, Pereira SL, et al. Effects of beta-hydroxy beta-methylbutyrate (HMB) supplementation on muscle mass, function, and other outcomes in patients with cancer: a systematic review. Journal of Cachexia, Sarcopenia and Muscle. 2022;13(3):1623-1641.
- Chew STH, et al. Oral nutritional supplement with beta-hydroxy-beta-methylbutyrate (HMB) improves nutrition, physical performance and ameliorates intramuscular adiposity in pre-frail older adults: a randomized controlled trial. J Nutr Health Aging. 2021 Mar17;25(6):767773.
- Iowa State University / 1996 press coverage of HMB’s commercial launch. The Spokesman-Review. Tue., April 16, 1996
